METTL5 and allergic respiratory disease: Thus, Mettl5 acts as a positive regulator of airway allergy by weakening M2 immunosuppression and promoting Th2 responses, suggesting that its inhibition may represent a therapeutic strategy for allergic diseases (Zheng et al., 2025).